A unique T cell subset described as CD410CD40+ T cells (TCD40) in human type 1 diabetes

被引:48
|
作者
Waid, Dan M.
Wagner, Rebecca J.
Putnam, Amy
Vaitaitis, Gisela M.
Pennock, Nathan D.
Calverley, David C.
Gottlieb, Peter
Wagner, David H., Jr.
机构
[1] Univ Colorado, Dept Med, Denver, CO 80262 USA
[2] Hlth Sci Ctr, Denver, CO 80262 USA
[3] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA
[4] Hlth Sci Ctr, Aurora, CO USA
[5] Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA USA
[6] Denver VA Med Ctr, Med & Res Serv, Denver, CO 80220 USA
关键词
type; 1; diabetes; auto-reactive T cells; autoimmunity; CD40;
D O I
10.1016/j.clim.2007.05.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human T1D pancreatic lymph nodes contain diabetes-autoantigen responsive T cells but identification of such T cells in the periphery has proven difficult. Here we describe a unique T cell subset defined by CD4(10) and CD40 expression (T-CD40) that is significantly expanded in peripheral blood of T1D but not control or T2D subjects. The HLA-DR3 and DR4 alleles are considered high risk factors for T1D and TCD40 expansion occurs in T1D subjects carrying HLA DR3 or DR4 haplotypes but, T1D subjects who do not carry either DR3 or DR4 haplotypes still have an expanded percentage of TCD40 cells. Non-autoimmune subjects, even DR3(+) and DR4(+), do not have elevated percentages of T-CD40 cells. The majority of T-CD40 cells in T1D carry a memory phenotype and a portion of those proliferates when exposed to diabetes-associated self-antigens. A greater number of memory T-CD40 cells express CXCR3 when compared to CD40(-) memory cells and that number is significantly expanded in T1D compared to control subjects. If only total CD4(+) T cells are compared no difference in CXCR3 is seen. Furthermore, T-CD40 cells produce a Th1, pro-inflammatory cytokine profile. In healthy controls, T-CD40 cells have equally Th1 and Th2 profiles. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:138 / 148
页数:11
相关论文
共 50 条
  • [31] An altered CD8+ T cell epitope of insulin prevents type 1 diabetes in humanized NOD mice
    Zhang, Mengjun
    Wang, Shufeng
    Guo, Binbin
    Meng, Gang
    Shu, Chi
    Mai, Wenli
    Zheng, Qian
    Chen, Xiaoling
    Wu, Yuzhang
    Wang, Li
    CELLULAR & MOLECULAR IMMUNOLOGY, 2019, 16 (06) : 590 - 601
  • [32] Differential lipid signaling from CD4+ and CD8+ T cells contributes to type 1 diabetes development
    White, Tayleur D.
    Almutairi, Abdulaziz
    Gai-Tusing, Ying
    Stephenson, Daniel J.
    Stephenson, Benjamin D.
    Chalfant, Charles E.
    Lei, Xiaoyong
    Lu, Brian
    Hammock, Bruce D.
    Dilorenzo, Teresa P.
    Ramanadham, Sasanka
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [33] Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes
    Long, S. Alice
    Thorpe, Jerill
    Herold, Kevan C.
    Ehlers, Mario
    Sanda, Srinath
    Lim, Noha
    Linsley, Peter S.
    Nepom, Gerald T.
    Harris, Kristina M.
    CELLULAR IMMUNOLOGY, 2017, 319 : 3 - 9
  • [34] Induction of CD4+CD25+Foxp3+regulatory T cell response by glatiramer acetate in type 1 diabetes
    Cui, Guoliang
    Zhang, Yuebo
    Gong, Zhenwei
    Zhang, Jingwu Z.
    Zang, Ying Qin
    CELL RESEARCH, 2009, 19 (05) : 574 - 583
  • [35] The A-chain of insulin is a hot-spot for CD4+ T cell epitopes in human type 1 diabetes
    Mannering, S. I.
    Pang, S. H.
    Williamson, N. A.
    Naselli, G.
    Reynolds, E. C.
    O'Brien-Simpson, N. M.
    Purcell, A. W.
    Harrison, L. C.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 156 (02) : 226 - 231
  • [36] Peripheral autoreactive CD8 T-cell frequencies are too variable to be a reliable predictor of disease progression of human type 1 diabetes
    Wesley, Johnna D.
    Pfeiffer, Susanne
    Schneider, Darius
    Friedrich, David
    Perdue, Nikole
    Sehested-Hansen, Birgit
    Hagopian, William
    von Herrath, Matthias G.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (07)
  • [37] MicroRNAs in CD4+ T cell subsets are markers of disease risk and T cell dysfunction in individuals at risk for type 1 diabetes
    Zhang, Yuxia
    Feng, Zhi-Ping
    Naselli, Gaetano
    Bell, Fiona
    Wettenhall, James
    Auyeung, Priscilla
    Ellis, Justine A.
    Ponsonby, Anne-Louise
    Speed, Terence P.
    Chong, Mark M. W.
    Harrison, Leonard C.
    JOURNAL OF AUTOIMMUNITY, 2016, 68 : 52 - 61
  • [38] The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives
    Luce, S.
    Briet, C.
    Becourt, C.
    Lemonnier, F.
    Boitard, C.
    DIABETES OBESITY & METABOLISM, 2013, 15 : 89 - 97
  • [39] Proteomic Landscape of Patient-Derived CD4+T Cells in Recent-Onset Type 1 Diabetes
    Lepper, Marlen F.
    Ohmayer, Uli
    von Toerne, Christine
    Maison, Nicole
    Ziegler, Anette-Gabriele
    Hauck, Stefanie M.
    JOURNAL OF PROTEOME RESEARCH, 2018, 17 (01) : 618 - 634
  • [40] Interleukin-7-dependent nonclassical monocytes and CD40 expression are affected in children with type 1 diabetes
    Hehenkamp, Paul
    Hoffmann, Maximilian
    Kummer, Sebastian
    Reinauer, Christina
    Doeing, Carsten
    Foertsch, Katharina
    Enczmann, Jurgen
    Balz, Vera
    Mayatepek, Ertan
    Meissner, Thomas
    Jacobsen, Marc
    Seyfarth, Julia
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (12) : 3214 - 3227